These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20087682)

  • 1. Cell type-specific regulation of IL-10 expression in inflammation and disease.
    Hedrich CM; Bream JH
    Immunol Res; 2010 Jul; 47(1-3):185-206. PubMed ID: 20087682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10-producing lymphocytes in inflammatory disease.
    Yao Y; Simard AR; Shi FD; Hao J
    Int Rev Immunol; 2013 Jun; 32(3):324-36. PubMed ID: 23617759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of IL-10 and its cell-specific role in vivo.
    MacKenzie KF; Pattison MJ; Arthur JS
    Crit Rev Immunol; 2014; 34(4):315-45. PubMed ID: 24941159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.
    O'Garra A; Vieira PL; Vieira P; Goldfeld AE
    J Clin Invest; 2004 Nov; 114(10):1372-8. PubMed ID: 15545984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor 2-Tpl2-Dependent ERK Signaling Drives Inverse Interleukin 12 Regulation in Dendritic Cells and Macrophages.
    Groft SG; Nagy N; Boom WH; Harding CV
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammation.
    Liao CT; Rosas M; Davies LC; Giles PJ; Tyrrell VJ; O'Donnell VB; Topley N; Humphreys IR; Fraser DJ; Jones SA; Taylor PR
    Eur J Immunol; 2016 Sep; 46(9):2222-32. PubMed ID: 27378515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response.
    Giacomini E; Iona E; Ferroni L; Miettinen M; Fattorini L; Orefici G; Julkunen I; Coccia EM
    J Immunol; 2001 Jun; 166(12):7033-41. PubMed ID: 11390447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.
    Iyer SS; Cheng G
    Crit Rev Immunol; 2012; 32(1):23-63. PubMed ID: 22428854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β induces expression of costimulatory molecules and cytokines but not immune feedback regulators in dendritic cells.
    Michelini S; Sarajlic M; Duschl A; Horejs-Hoeck J
    Hum Immunol; 2018 Aug; 79(8):610-615. PubMed ID: 29886260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The consequences of apoptosis in autoimmunity.
    Lleo A; Selmi C; Invernizzi P; Podda M; Gershwin ME
    J Autoimmun; 2008 Nov; 31(3):257-62. PubMed ID: 18513925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 and the interleukin-10 receptor.
    Moore KW; de Waal Malefyt R; Coffman RL; O'Garra A
    Annu Rev Immunol; 2001; 19():683-765. PubMed ID: 11244051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination.
    Llopiz D; Ruiz M; Infante S; Villanueva L; Silva L; Hervas-Stubbs S; Alignani D; Guruceaga E; Lasarte JJ; Sarobe P
    Oncotarget; 2017 Jan; 8(2):2659-2671. PubMed ID: 27926522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions and regulation of T cell-derived interleukin-10.
    Neumann C; Scheffold A; Rutz S
    Semin Immunol; 2019 Aug; 44():101344. PubMed ID: 31727465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases.
    Papotto PH; Reinhardt A; Prinz I; Silva-Santos B
    J Autoimmun; 2018 Feb; 87():26-37. PubMed ID: 29203226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation.
    Ouyang W; O'Garra A
    Immunity; 2019 Apr; 50(4):871-891. PubMed ID: 30995504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling.
    Samarasinghe R; Tailor P; Tamura T; Kaisho T; Akira S; Ozato K
    J Interferon Cytokine Res; 2006 Dec; 26(12):893-900. PubMed ID: 17238832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-21: a double-edged sword with therapeutic potential.
    Spolski R; Leonard WJ
    Nat Rev Drug Discov; 2014 May; 13(5):379-95. PubMed ID: 24751819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development.
    Igietseme JU; Ananaba GA; Bolier J; Bowers S; Moore T; Belay T; Eko FO; Lyn D; Black CM
    J Immunol; 2000 Apr; 164(8):4212-9. PubMed ID: 10754317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.